Email this article Prospects for the Use of Genome-Editing Technology to Correct Neurodegenerative Diseases
- Authors: Stepanichev M.Y.1
-
Affiliations:
- Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
- Issue: Vol 9, No 2 (2019)
- Pages: 154-163
- Section: Article
- URL: https://journals.rcsi.science/2079-0570/article/view/206347
- DOI: https://doi.org/10.1134/S2079057019020218
- ID: 206347
Cite item
Open Access
Access granted
Subscription Access
Abstract
The review analyzes the results of modern studies that involve gene therapy methods for the correction of neurodegenerative diseases. Approaches based on gene-editing technologies and their prospective use in medicine are considered. There may be limitations to the use of the genome-editing tools in the treatment of these pathologies due to features of the pathogenesis of neurodegenerative diseases.
About the authors
M. Yu. Stepanichev
Institute of Higher Nervous Activity and Neurophysiology, Russian Academy of Sciences
Author for correspondence.
Email: m_step_68@mail.ru
Russian Federation, Moscow, 117485
